Displaying 13 - 24 of 79
Viral Hepatitis

GSK: Time to rethink chronic hepatitis B: Quantitative hepatitis B surface antigen today and tomorrow (Complete Session)

Webcasts
View
Viral Hepatitis

Gilead: AChievaBle toDay: For all patients with viral hepatitis (Complete Session)

Webcasts
View
Viral Hepatitis

Clinical Care Solutions: Building the Backbone of Chronic Hepatitis B Management with Emerging Therapies (Complete Session)

Webcasts
View
Viral Hepatitis

GSK: Destination functional cure in CHB: Exploring new terrain (Complete Session)

Webcasts
View
Viral Hepatitis

AbbVie: Educate, Motivate, Prioritize, Adapt: Decentralizing Care to Eliminate HCV (Complete Session)

Webcasts
View
Viral Hepatitis

GSK: ​Destination functional cure in CHB: ​What’s driving us ? (Complete Session)

Webcasts
View
Viral Hepatitis
Exploring Functional Cure in Chronic Hepatitis B

Exploring Functional Cure in Chronic Hepatitis B

Webcasts
View
Viral Hepatitis
Quantitative hepatitis B surface antigen (qHBsAg) is a useful biomarker for Chronic Hepatitis B

Quantitative hepatitis B surface antigen (qHBsAg) is a useful biomarker for Chronic Hepatitis B

PDF
View
Viral Hepatitis

AbbVie: "Test + treat = Cure. Is the HCV elimination formula really that simple?" (Complete Session)

Webcasts
View
Viral Hepatitis

GSK: “Looking to the future of hepatitis B: how can we achieve functional cure?” (Complete Session)

Webcasts
View
Viral Hepatitis

Gilead: "Headlines In Hepatitis Delta: The Latest Advances In Care in Hepatitis Delta" (Complete Session)

Webcasts
View
Viral Hepatitis

Gilead: “From Headlines To The Clinic: Expert Approaches To Patient Care in Hepatitis Delta” (Complete Session)

Webcasts
View
Displaying 13 - 24 of 79